ATE320831T1 - Immunotrophische preparation zur behandlung von tonsilläre hypertrophie - Google Patents

Immunotrophische preparation zur behandlung von tonsilläre hypertrophie

Info

Publication number
ATE320831T1
ATE320831T1 AT00830659T AT00830659T ATE320831T1 AT E320831 T1 ATE320831 T1 AT E320831T1 AT 00830659 T AT00830659 T AT 00830659T AT 00830659 T AT00830659 T AT 00830659T AT E320831 T1 ATE320831 T1 AT E320831T1
Authority
AT
Austria
Prior art keywords
preparation
hypertrophy
immunotrophic
tonsilar
treatment
Prior art date
Application number
AT00830659T
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8175505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE320831(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Application granted granted Critical
Publication of ATE320831T1 publication Critical patent/ATE320831T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00830659T 2000-10-06 2000-10-06 Immunotrophische preparation zur behandlung von tonsilläre hypertrophie ATE320831T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00830659A EP1195178B1 (de) 2000-10-06 2000-10-06 Immunotrophische Preparation zur Behandlung von tonsilläre Hypertrophie

Publications (1)

Publication Number Publication Date
ATE320831T1 true ATE320831T1 (de) 2006-04-15

Family

ID=8175505

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00830659T ATE320831T1 (de) 2000-10-06 2000-10-06 Immunotrophische preparation zur behandlung von tonsilläre hypertrophie

Country Status (4)

Country Link
EP (1) EP1195178B1 (de)
AT (1) ATE320831T1 (de)
DE (1) DE60026816T2 (de)
PT (1) PT1195178E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060421A1 (it) * 2006-08-03 2008-02-04 Dmg Italia Srl Preparato immunotrofico a base di fosfoglucano per il trattamento della ipertrofia adenotonsillare

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU942757A1 (ru) * 1979-02-23 1982-07-15 Киевский Научно-Исследовательский Институт Оториноларингологии Способ лечени хронического тонзиллита
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
GB9510037D0 (en) * 1995-05-18 1995-07-12 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
JPH11228387A (ja) * 1998-02-05 1999-08-24 Taisho Pharmaceut Co Ltd ヨード系殺菌剤を含有する薬用組成物
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise

Also Published As

Publication number Publication date
DE60026816T2 (de) 2006-10-12
PT1195178E (pt) 2006-10-31
DE60026816D1 (de) 2006-05-11
EP1195178A1 (de) 2002-04-10
EP1195178B1 (de) 2006-03-22

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
DE50115336D1 (de) Verfahren zur herstellung von pektinhydrolyseprodukten
TW200744478A (en) Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
ID18254A (id) Pemicu yang dapat diinduksi oleh garam yang dapat diturunkan dari bakteri asam laktat, dan penggunaannya dalam bakteri asam laktat untuk produksi protein yang diinginkan
ATE232393T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
BR0009163A (pt) Vacina
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE289164T1 (de) Cis-jasmon als semio-chemikalie
SE0003544L (sv) Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
WO2004032849A3 (en) Methods of administering fgf18
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
DE60123475D1 (de) Pasteurisieren oder sterilisieren
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
MXPA02011389A (es) Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion.
CA2317465A1 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
CA2083243A1 (en) Process for the production of a virus-free concentrate of thrombin
ATE320831T1 (de) Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
CA2411582A1 (en) Method for increasing the antioxidative potential of selenium-containing aqueous solutions
RU2005105064A (ru) Оральная композиция, обеспечивающая гигиену полости рта с улучшенными свойствами
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
WO2000040699A3 (en) Astrocytes, their preparation and uses thereof
DE60111544D1 (de) Verfahren zur herstellung von tomatenflocken
官文惠 An Ideal Holiday
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1195178

Country of ref document: EP